Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
World Journal of Gastroenterology|August 30, 2014
Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatmentCarlo Visco, Silvia FinottoAmerican Journal of Hematology|March 2, 2013
The combination of rituximab, bendamustine, and cytarabine for heavily pretreated relapsed/refractory cytogenetically high-risk patients with chronic lymphocytic leukemiaCarlo Visco, Silvia Finotto, Fabrizio Pomponi, et al.Leukemia & Lymphoma|September 20, 2013
Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?Carlo Visco, Agostino Cortelezzi, Francesca Moretta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantationCarlo Visco, Silvia Finotto, Renato Zambello, et al.Hematological Oncology|July 18, 2013
B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalitiesErika Falisi, Elisabetta Novella, Carlo Visco, et al.Hematology/Oncology Clinics of North America|November 26, 2009
Immune thrombocytopenia in lymphoproliferative disordersCarlo Visco, Francesco RodeghieroTherapeutic Advances in Hematology|February 5, 2025
Management of mycosis fungoides and Sézary syndrome with mogamulizumab in combination with psoralen plus UVA: two case reportsAndrea Bernardelli, Carlo ViscoBritish Journal of Haematology|July 7, 2025
We are on the right track for mantle cell lymphomaAlessia Moioli, Carlo ViscoHaematologica|January 20, 2022
The mitochondrial anti-apoptotic dependencies of hematologic malignancies: from disease biology to advances in precision medicineIsacco Ferrarini, Antonella Rigo, Carlo ViscoPageof 19